Universität zu Köln

Journal Article

Depuydt, Pauline, Boeva, Valentina ORCID: 0000-0002-4382-7185, Hocking, Toby D., Cannoodt, Robrecht ORCID: 0000-0003-3641-729X, Ambros, Inge M., Ambros, Peter F. ORCID: 0000-0002-5507-7211, Asgharzadeh, Shahab, Attiyeh, Edward F., Combaret, Valerie, Defferrari, Raffaella, Fischer, Matthias, Hero, Barbara, Hogarty, Michael D., Irwin, Meredith S., Koster, Jan ORCID: 0000-0002-0890-7585, Kreissman, Susan, Ladenstein, Ruth, Lapouble, Eve, Laureys, Genevieve, London, Wendy B., Mazzocco, Katia ORCID: 0000-0002-6599-5681, Nakagawara, Akira, Noguera, Rosa, Ohira, Miki, Park, Julie R., Poetschger, Ulrike, Theissen, Jessica, Tonini, Gian Paolo, Valteau-Couanet, Dominique, Varesio, Luigi, Versteeg, Rogier ORCID: 0000-0001-7172-0388, Speleman, Frank, Maris, John M., Schleiermacher, Gudrun and De Preter, Katleen (2018). Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients. JNCI-J. Natl. Cancer Inst., 110 (10). CARY: OXFORD UNIV PRESS INC. ISSN 1460-2105

Fischer, Matthias, Moreno, Lucas, Ziegler, David S., Marshall, Lynley, V, Zwaan, C. Michel, Irwin, Meredith S., Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K., Branle, Fabrice, Geoerger, Birgit and Schulte, Johannes H. (2021). Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study. Lancet Oncol., 22 (12). S. 1764 - 1777. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Moreno, Lucas, Barone, Giuseppe, DuBois, Steven G., Molenaar, Jan, Fischer, Matthias, Schulte, Johannes, Eggert, Angelika ORCID: 0000-0003-3476-8184, Schleiermacher, Gudrun, Speleman, Frank, Chesler, Louis, Geoerger, Birgit, Hogarty, Michael D., Irwin, Meredith S., Bird, Nick, Blanchard, Guy B., Buckland, Sean, Caron, Hubert, Davis, Susan, De Wilde, Bram, DeubZer, Hedwig E., Dolman, Emmy, Eilers, Martin, George, Rani E., George, Sally, Sterba, Jaroslav, Maris, John M., Marshall, Lynley, Merchant, Melinda, Mortimer, Peter, Owens, Cormac, Philpott, Anna, Poon, Evon, Shay, Jerry W., Tonelli, Roberto, Valteau-Couanet, Dominique, Vassal, Gilles, Park, Julie R. and Pearson, Andrew D. J. (2020). Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. Eur. J. Cancer, 136. S. 52 - 69. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Moreno, Lucas, Guo, Dongjing, Irwin, Meredith S., Berthold, Frank ORCID: 0000-0002-7613-1723, Hogarty, Michael ORCID: 0000-0002-9221-4852, Kamijo, Takehiko, Morgenstern, Daniel ORCID: 0000-0002-4859-1108, Pasqualini, Claudia, Ash, Shifra, Potschger, Ulrike, Ladenstein, Ruth, Valteau-Couanet, Dominique, Cohn, Susan L., Pearson, Andrew D. J. and London, Wendy B. . A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project. Pediatr. Blood Cancer. HOBOKEN: WILEY. ISSN 1545-5017

Morgenstern, Daniel A., London, Wendy B., Stephens, Derek, Volchenboum, Samuel L., Hero, Barbara, Di Cataldo, Andrea ORCID: 0000-0002-4509-3066, Nakagawara, Akira, Shimada, Hiroyuki, Ambros, Peter F., Matthay, Katherine K., Cohn, Susan L., Pearson, Andrew D. J. and Irwin, Meredith S. (2014). Metastatic Neuroblastoma Confined to Distant Lymph Nodes (stage 4N) Predicts Outcome in Patients With Stage 4 Disease: A Study From the International Neuroblastoma Risk Group Database. J. Clin. Oncol., 32 (12). S. 1228 - 1240. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Morgenstern, Daniel A., London, Wendy B., Stephens, Derek, Volchenboum, Samuel L., Simon, Thorsten, Nakagawara, Akira, Shimada, Hiroyuki, Schleiermacher, Gudrun, Matthay, Katherine K., Cohn, Susan L., Pearson, Andrew D. J. and Irwin, Meredith S. (2016). Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database. Eur. J. Cancer, 65. S. 1 - 11. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852